-+ 0.00%
-+ 0.00%
-+ 0.00%

NEURIMMUNE: SOLD PORTION OF ITS ROYALTY INTEREST IN CLIRAMITUG TO ROYALTY PHARMA FOR UP TO $425 MLN

Reuters·07/22/2026 10:50:06

Please log in to view news